Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 28, 2026; 32(40): 121401
Published online Oct 28, 2026. doi: 10.3748/wjg.121401
Published online Oct 28, 2026. doi: 10.3748/wjg.121401
Table 5 Quartile-specific prevalence of steatotic liver disease according to triglyceride glucose-waist-to-height ratio levels
| Quartile | TyG-WHtR range | n | SLD cases | SLD prevalence (%) | Unadjusted OR (95%CI) |
| Q1 (lowest) | ≤ P25 | 129 | 7 | 5.4 | 1.00 (Reference) |
| Q2 | P25-P50 | 129 | 57 | 44.2 | 13.80 (5.97-31.88) |
| Q3 | P50-P75 | 130 | 94 | 72.3 | 45.51 (19.39-106.80) |
| Q4 (highest) | > P75 | 129 | 115 | 89.1 | 143.16 (55.80-366.90) |
| P for trend | < 0.0001 |
- Citation: Li ZK, Cai JT, Zhang PH, Wang LL, Yan HH. Assessment indicators of steatotic liver disease in non-hepatology specialty clinics: A real-world retrospective case-control study. World J Gastroenterol 2026; 32(40): 121401
- URL: https://www.wjgnet.com/1007-9327/full/v32/i40/121401.htm
- DOI: https://dx.doi.org/10.3748/wjg.121401